TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Cardiovascular Diseases
Division of General Internal Medicine
更新時間：2023-09-19
李啟明LEE, CHII-MING
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
61Publications
1
Huang NC, Lee CM, Hsu S. Effective naked plasmid DNA delivery into stem cells by microextrusion-based transient-transfection system for in situ cardiac repair. Cytotherapy 2020;22(2):70-81.
2
Lin M, Chen WC, Wu CH, Chen SY, Lee CM. The effectiveness of cardiac rehabilitation in non-ischemic dilated cardiomyopathy patients: A pilot study. J Formosan Med Assoc 2020;119(2):627-634
3
Wang C, Wu C, Tsai M, Lee CM, et al. 2019 focused update of the guidelines of the Taiwan society of cardiology for the diagnosis and treatment of heart failure. Acta Cardiol Sinica 2019;35(3):244-283
4
Hsu WT, Lin CH, Jui HY, Tseng YH, Shun CT, Hsu MC, Wu KK, Lee CM*. CXCR4 antagonist reduced the incidence of acute rejection and controlled cardiac allograft vasculopathy in a swine heart transplant model receiving a mycophenolate-based immunosuppressive regimen. Transplantation 2018;102(12):2002-2011.
5
Cheng JF, Lee SH, Hsu RB, Yu SC, Shun CT, Huang PS, Chen YH, Lee CM*. Fulminant primary cardiac lymphoma with sudden cardiac death: A case report and brief review. J Formos Med Assoc. 2018;117(10):939-943. doi: 10.1016/j.jfma.2018.03.011. Epub 2018 Apr 19. Review. PMID:29681417
6
Liang HW, Kao HL, Lin YH, Hwang JJ, Lin MS, Chiang FT, Lee CM, Yeh CF, Wang TD, Wu CK, Lin LY, Tsai CT, Chen YH. Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience. Acta Cardiol Sinica 2017;33(3):250-257
7
Wang CY, Lin ZF, Lee CM, Tsai YW, Huang TY, Shen LJ, Hsiao FY. Concomitant use of calcium channel blockers with dual antiplatelet therapy and re-hospitalization for acute coronary syndrome. Pharmacoepidemiol Drug Safety 2017;26(3):229-238
8
Lin YT, Lin YH, Wu XM, Ko CL, Yen RF, Chen YH, Hsu RB, Lee CM, Wang SS, Chen MF, Wu YW. The relationship between serum fibrosis markers and restrictive ventricular filling in patients with heart failure with reduced ejection fraction: A technetium-99m radionuclide ventriculography study. Oncotarget 2017;8(2):2381-2390. doi: 10.18632/oncotarget.13795. PMID:27924061
9
Lin YH, Kuo CC, Lee CM, Chou CH, Chen YH, Yeh JF, Huang CC, Hung CS, Liu LD, Ho YL, Wu KK. 5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - a preliminary approach to clinical utility. Int J Cardiol 2016;222:895-900. doi: 10.1016/j.ijcard.2016.07.293. PMID:27526355
10
Hsu WT, Shen LJ, Lee CM*. Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management. J Formos Med Assoc 2016;115(5):335-42. doi:10.1016/j.jfma.2015.11.014.PMID:26774679
